1 active not recruiting, 1 not yet recruiting, 1 recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Active not recruiting 1, Not yet recruiting 1, Recruiting 1 |
Follow Tobacco: new trials by email Literature Review of Tobacco trials Research Report on Tobacco
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Daridorexant on Sleep, Daytime Alertness, and Smoking Daridorexant 50 mg, Placebo - Smoking, Nicotine | Phase 4 | Not yet recruiting | Legacy Health System | 44 | 2026-02-10 | 2026-01-09 |
| Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation Nicotine Replacement Therapy (Nicotine patch plus NRT gum or lozenge), Cytisine, Varenicline (Champix) - Tobacco | Phase 4 | Recruiting | Ottawa Heart Institute Research Corporation | 150 | 2025-04-30 | 2026-03-05 |
| Secondhand Smoke Respiratory Health Study Albuterol, Placebo - Secondhand Smoke, Air Trapping | Phase 4 | Active not recruiting | University of California, San Francisco | 107 | 2016-06-06 | 2026-06-04 |
Behavior, Addictive (1) · Lung Diseases, Obstructive (1) · Sleep Initiation and Maintenance Disorders (1) · Smoking (1) · Substance-Related Disorders (1) · Tobacco Use Cessation (1)
Behavior (2) · Chemically-Induced Disorders (1) · Compulsive Behavior (1) · Dyssomnias (1) · Health Behavior (1) · Impulsive Behavior (1) · Lung Diseases (1) · Mental Disorders (1) · Nervous System Diseases (1) · Respiratory Tract Diseases (1) · Sleep Disorders, Intrinsic (1) · Sleep Wake Disorders (1)
Albuterol (1) · Nicotine Replacement Therapy (1) · Procaterol (1) · Tobacco Use Cessation Devices (1) · Varenicline (1) · cytisine (1) · daridorexant (1)
Legacy Health System (1) · Ottawa Heart Institute Research Corporation (1) · University of California, San Francisco (1)
United States (2) · Canada (1)